Sphera Funds Management Ltd. Discloses 7.31% Passive Stake In Praxis Precision Medicines
Portfolio Pulse from Benzinga Newsdesk
Sphera Funds Management Ltd. has disclosed a 7.31% passive stake in Praxis Precision Medicines, a clinical-stage biopharmaceutical company.
June 22, 2023 | 3:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sphera Funds Management Ltd. has taken a 7.31% passive stake in Praxis Precision Medicines, potentially increasing investor interest.
Sphera Funds Management Ltd.'s disclosure of a 7.31% passive stake in Praxis Precision Medicines may lead to increased investor interest in the stock. As a result, the stock price may experience a short-term positive impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100